NLS Pharmaceutics Says It Submited Plan To Regain Listing Compliance With Nasdaq
NLS Pharmaceutics表示已提交恢复纳斯达克上市合规性的计划
NLS Pharmaceutics Says It Submited Plan To Regain Listing Compliance With Nasdaq
NLS Pharmaceutics表示已提交恢复纳斯达克上市合规性的计划
使用浏览器的分享功能,分享给你的好友吧